Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease
Aim. To assess the quality of life of patients with stable coronary heart disease (CHD) initially and 12 months after drug and non-drug secondary prophylaxis according to clinical guidelines.Material and methods. 73 patients (57 men, 16 women) with confirmed stable coronary artery disease were inclu...
Saved in:
Main Authors: | E. D. Zharkova (Author), Yu. V. Lukina (Author), N. P. Kutishenko (Author), E. T. Huseynova (Author), N. P. Zolotareva (Author), S. Yu. Martsevich (Author), O. M. Drapkina (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of the Quality of Drug Therapy in Patients with Stable Coronary Artery Disease in the Second Stage of the ALIGN Study
by: E. D. Zharkova, et al.
Published: (2022) -
An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results
by: S. Yu. Martsevich, et al.
Published: (2020) -
Treatment Adherence to Drug Therapyin Patients with Stable Coronary Artery Disease During the COVID-19 Pandemic
by: S. Y. Martsevich, et al.
Published: (2021) -
Efficacy, Safety and Long-term Outcomes of Nicorandil Use in Patients with Stable Ischemic Heart Disease According to the Results of Randomized and Observational Studies
by: Yu. V. Lukina, et al.
Published: (2019) -
THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY
by: S. Yu. Martsevich, et al.
Published: (2017)